Liangliang Qiao

Liangliang Qiao

Auto-generated profile, based on publicly available information

Liangliang Qiao

Department of Interventional Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Radiology
Verified
Journal Article
Closed access
HLHaikuan Liu
Haikuan Liu
WFWenzhe Fan
Wenzhe Fan
HLHaiqing Li
Haiqing Li
LQLiangliang Qiao
Liangliang Qiao
ZLZhilong Liu
Zhilong Liu
JLJiaping Li
Jiaping Li
Compared with epirubicin, idarubicin increased survival rates in participants with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma undergoing drug-eluting bead transarterial chemoembolization without an increase adverse event incidence.